Every SEC Form 3/4/5 on record for this filer (CIK 1349297) — 6 issuers, 31 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| THC | TENET HEALTHCARE CORP | Director | 2018-06-04 → 2026-05-28 | 16 | −$4M |
| ROIV | Roivant Sciences Ltd. | Director | 2023-03-16 → 2026-03-30 | 11 | −$2M |
| PEAR | Pear Therapeutics, Inc. | Filer · lapsed | 2021-12-06 → 2021-12-06 | 1 | — |
| THMAU | Thimble Point Acquisition Corp. | Director · lapsed | 2021-02-01 → 2021-02-01 | 1 | — |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Director · lapsed | 2016-03-23 → 2018-06-18 | 4 | — |
| CAH | CARDINAL HEALTH INC | EVP, Strategy & Health Policy · lapsed | 2015-08-06 → 2015-11-17 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ROIV | 2026-03-26 | Sell | 70,000 | $27.45 | $2M | 42,963 |
3 of 6 issuers are covered and open a security page; the rest are on file here only.
